Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05745701 · ClinicalTrials.gov registry record · Phase 1
A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT05745701 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 16 participants.
The verdict
NCT05745701, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is a Phase 1, open-label, fixed-sequence, 3-period study to evaluate the effect of multiple doses of itraconazole and a single dose of cyclosporine on the single-dose PK of PF-07081532 in otherwise healthy, overweight or obese, adult female and male participants. The 3 study periods will be conducted consecutively without a break.
Interventions
- DRUG Itraconazole
- DRUG PF-07081532
- DEVICE Cyclosporine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-02-22 |
| Est. Completion | 2023-05-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05745701
The ClinicalTrials.gov registry entry for NCT05745701 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Itraconazole is the first listed.
NCT05745701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05745701 about?
NCT05745701 is a clinical study titled "A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults". This is a Phase 1, open-label, fixed-sequence, 3-period study to evaluate the effect of multiple doses of itraconazole and a single dose of cyclosporine on the single-dose PK of PF-07081532 in otherwise healthy, overweight or obese, adult female and male participants. The 3 study periods will be co...
What is the current status of trial NCT05745701?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2023-02-22. Estimated completion is 2023-05-29.
What interventions are being tested in trial NCT05745701?
The interventions under investigation include: Itraconazole (DRUG), PF-07081532 (DRUG), Cyclosporine (DEVICE).
Who is sponsoring clinical trial NCT05745701?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.